Kawamura, T., Tanaka, H., Tachibana, R., Yoshikawa, K., Maki, S., Toriyabe, K., . . . Ikeda, T. (2021). Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring. Sci Rep.
Παραπομπή Chicago StyleKawamura, Takuya, et al. "Maternal Tadalafil Therapy for Fetal Growth Restriction Prevents Non-alcoholic Fatty Liver Disease and Adipocyte Hypertrophy in the Offspring." Sci Rep 2021.
Παραπομπή MLAKawamura, Takuya, et al. "Maternal Tadalafil Therapy for Fetal Growth Restriction Prevents Non-alcoholic Fatty Liver Disease and Adipocyte Hypertrophy in the Offspring." Sci Rep 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.